Having completed the lengthy registration, Coreleader Bio is proudly announce its plan to embrace countries in Middle East soon. 

First shipment is completed and loaded for delivery. The customers in the region will be free from the poor quality of those branded products but actually sourced from mainland China. The quality fails to justify its price. Touchdown of Coreleader simply offers a new option to medical staff in the region to apply a real good product to the patients they concerned so much, 

Mr. Tsao, the CEO of the innovative biotech company, addressed in a recent new conference that given the rocketing increase of diabetes patients, Coreleader's goal is to work with doctors and nurses to serve the sick people right so to not only penetrate to the regional market but also grow in the market.  The bio company would like to be recognized by their peers as the leader in the product quality and innovation.